JPY 1232.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 6.31 Billion JPY | 13.76% |
2022 | 5.05 Billion JPY | 65.96% |
2021 | 5.37 Billion JPY | 16.24% |
2020 | 2.84 Billion JPY | 23.48% |
2019 | 2.33 Billion JPY | 25.99% |
2018 | 2.12 Billion JPY | 29.11% |
2017 | 1.42 Billion JPY | 16.41% |
2016 | 1.23 Billion JPY | 72.91% |
2015 | 716.45 Million JPY | 98.8% |
2014 | 443.74 Million JPY | -53.7% |
2013 | 772.6 Million JPY | -16.0% |
2012 | 922.52 Million JPY | -4.58% |
2011 | 968.72 Million JPY | -1.54% |
2010 | 887.82 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 1.2 Billion JPY | -66.02% |
2023 Q4 | 3.16 Billion JPY | 176.82% |
2023 FY | - JPY | 13.76% |
2023 Q3 | 1.14 Billion JPY | 8.65% |
2023 Q1 | 726 Million JPY | -74.74% |
2023 Q2 | 1.05 Billion JPY | 44.9% |
2022 Q4 | 2.87 Billion JPY | 365.8% |
2022 Q1 | 570 Million JPY | 1.83% |
2022 FY | - JPY | 65.96% |
2022 Q3 | 617 Million JPY | -2.06% |
2022 Q2 | 630 Million JPY | 10.53% |
2021 Q3 | 1.09 Billion JPY | 117.63% |
2021 FY | - JPY | 16.24% |
2021 Q1 | 410.74 Million JPY | -21.45% |
2021 Q2 | 503.18 Million JPY | 22.5% |
2021 Q4 | 559.75 Million JPY | -48.88% |
2020 FY | - JPY | 23.48% |
2020 Q4 | 522.91 Million JPY | -6.1% |
2020 Q3 | 556.88 Million JPY | -23.1% |
2020 Q2 | 724.15 Million JPY | 34.94% |
2020 Q1 | 536.63 Million JPY | 0.7% |
2019 FY | - JPY | 25.99% |
2019 Q3 | 445.86 Million JPY | -6.69% |
2019 Q2 | 477.85 Million JPY | 11.6% |
2019 Q1 | 428.17 Million JPY | -6.34% |
2019 Q4 | 532.89 Million JPY | 19.52% |
2018 Q1 | 301.9 Million JPY | -39.35% |
2018 FY | - JPY | 29.11% |
2018 Q4 | 457.15 Million JPY | 54.27% |
2018 Q3 | 296.33 Million JPY | -53.71% |
2018 Q2 | 640.14 Million JPY | 112.04% |
2017 Q2 | 229.14 Million JPY | 4.36% |
2017 FY | - JPY | 16.41% |
2017 Q1 | 219.55 Million JPY | -26.01% |
2017 Q4 | 497.77 Million JPY | 356.37% |
2017 Q3 | 109.07 Million JPY | -52.4% |
2016 Q3 | 168.88 Million JPY | -38.54% |
2016 Q1 | 164.72 Million JPY | -4.98% |
2016 Q4 | 296.74 Million JPY | 75.71% |
2016 Q2 | 274.77 Million JPY | 66.81% |
2016 FY | - JPY | 72.91% |
2015 Q4 | 173.34 Million JPY | 52.11% |
2015 Q3 | 113.96 Million JPY | -24.03% |
2015 Q2 | 150.02 Million JPY | 547.75% |
2015 Q1 | 23.16 Million JPY | -71.15% |
2015 FY | - JPY | 98.8% |
2014 Q2 | 46.61 Million JPY | 8.49% |
2014 FY | - JPY | -53.7% |
2014 Q4 | 80.28 Million JPY | 258.97% |
2014 Q3 | -50.5 Million JPY | -208.34% |
2014 Q1 | 42.96 Million JPY | -53.68% |
2013 Q3 | 95.08 Million JPY | -38.09% |
2013 Q2 | 153.59 Million JPY | -11.31% |
2013 Q1 | 173.17 Million JPY | -5.26% |
2013 FY | - JPY | -16.0% |
2013 Q4 | 92.76 Million JPY | -2.44% |
2012 Q3 | 158.9 Million JPY | -15.3% |
2012 Q2 | 187.6 Million JPY | 67.42% |
2012 Q1 | 112.05 Million JPY | -30.32% |
2012 FY | - JPY | -4.58% |
2012 Q4 | 182.77 Million JPY | 15.02% |
2011 FY | - JPY | -1.54% |
2011 Q4 | 160.81 Million JPY | -9.98% |
2011 Q3 | 178.63 Million JPY | 0.0% |
2010 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AS PARTNERS CO LTD | 1.07 Billion JPY | -484.36% |
I'rom Group Co., Ltd. | 2.27 Billion JPY | -177.851% |
Saint-Care Holding Corporation | 4.04 Billion JPY | -56.051% |
Artra Group Corporation | 228.12 Million JPY | -2666.076% |
UCHIYAMA HOLDINGS Co.,Ltd. | 1.23 Billion JPY | -411.059% |
Elan Corporation | 3.85 Billion JPY | -63.766% |
Solasto Corporation | 8.85 Billion JPY | 28.749% |
teno. Holdings Company Limited | 616 Million JPY | -924.351% |
Japan Hospice Holdings Inc. | 1.69 Billion JPY | -272.175% |
baby calendar Inc. | 11.62 Million JPY | -54184.24% |
Advantage Risk Management Co., Ltd. | 1.41 Billion JPY | -346.791% |